Dianthus Therapeutics
Price & Volume
Stats
See more52W Range | $13.36-$32.27 |
Market Cap | $682M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $6.2M |
Revenue Growth (YoY) | 190.2% |
Gross Profit (12 Mos) | $6.2M |
Diluted EPS | -$2.55 |
News
See moreYahoo Finance • 2 months ago
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results
Yahoo Finance • 2 months ago
Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors
Yahoo Finance • 2 months ago
Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences
Yahoo Finance • 3 months ago
Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences
About
CEO | Mr. Marino Garcia M.B.A. |
Address | 7 Times Square, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 78 |
